Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

10 Hedge Funds Hurt By the Decline in Apple $AAPL

Apple is currently trading at $315.56 near its lowest level in 2011.  Apple gained 8% during the first quarter, but declined 9.46% since then. The stock is also down 2.2% since the end of 2010. Apple’s poor performance clearly hurt several hedge funds that were extremely bullish about the stock. Here are the top 10 hedge funds hurt by the decline in Apple (AAPL):

1. Rob Citrone – Discovery Capital Management: Lost $60 Million since March 31st.

2. Stephen Mandel – Lone Pine Capital: Lost $51 Million since March 31st.

3. Phill Gross and Robert Atchinson – Adage Capital: Lost $48 Million since the end of March.

4. Chase Coleman – Tiger Global: LinkedIn milionaire lost $47 Million since the end of March.

5. Philippe Laffont – Coatue Management: Lost $45 Million since March 31st.

6. Lee Ainslie – Maverick Capital: Lost $39 Million since the end of March.

7. Jeffrey Altman – Owl Creek Asset Management: Lost $33 Million since March 31st.

8. John Griffin – Blue Ridge: Lost $32 Million since the end of March.

9. D.E. Shaw: Lost more than $28 Million.

10. David Einhorn – Greenlight Capital: Lost $27.6 Million during the second quarter.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!